v3.26.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
At-the-Market Offering
As Reported
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series A Preferred Stock
As Reported
Preferred Stock
Series B Preferred Stock
Preferred Stock
Series B Preferred Stock
As Reported
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
At-the-Market Offering
Common Stock
Class A Common Stock
February 2025 Private Placement
Common Stock
Class A Common Stock
As Reported
Common Stock
Class A Common Stock
Revision of Prior Period, Adjustment
Additional Paid-in Capital
Additional Paid-in Capital
At-the-Market Offering
Additional Paid-in Capital
As Reported
Accumulated Other Comprehensive Income (loss)
Accumulated Other Comprehensive Income (loss)
As Reported
Accumulated Deficit
Accumulated Deficit
As Reported
Beginning balance (in shares) at Dec. 31, 2024       167,972 167,972 0 0 54,678     54,739 (61)              
Beginning balance at Dec. 31, 2024 $ (12,896)   $ (12,896) $ 0 $ 0 $ 0 $ 0 $ 0     $ 0   $ 119,487   $ 119,487 $ 227 $ 227 $ (132,610) $ (132,610)
Shares issued for:                                      
Vesting of restricted share units (in shares)               106                      
Vesting of restricted share units (3)                       (3)            
Reverse stock split fractional adjustment (in shares)               1                      
Conversion of related-party debt to common stock / Warrants exercised (in shares)               11,542                      
ATM Program / February 2025 private placement (in shares)                   7,222                  
Stock compensation 144                       144            
Foreign currency translation 722                             722      
Fixed dividends Preferred Series B (634)                       (634)            
Net income (loss) (7,962)                                 (7,962)  
Ending balance (in shares) at Jun. 30, 2025       167,972   0   73,549                      
Ending balance at Jun. 30, 2025 (20,629)     $ 0   $ 0   $ 0         118,994     949   (140,572)  
Beginning balance (in shares) at Mar. 31, 2025       167,972   0   61,955                      
Beginning balance at Mar. 31, 2025 (15,815)     $ 0   $ 0   $ 0         119,241     797   (135,853)  
Shares issued for:                                      
Vesting of restricted share units (in shares)               52                      
Vesting of restricted share units (2)                       (2)            
Conversion of related-party debt to common stock / Warrants exercised (in shares)               11,542                      
Stock compensation 72                       72            
Foreign currency translation 152                             152      
Fixed dividends Preferred Series B (317)                       (317)            
Net income (loss) (4,719)                                 (4,719)  
Ending balance (in shares) at Jun. 30, 2025       167,972   0   73,549                      
Ending balance at Jun. 30, 2025 (20,629)     $ 0   $ 0   $ 0         118,994     949   (140,572)  
Beginning balance (in shares) at Dec. 31, 2025       167,972   1,586,620   228,335                      
Beginning balance at Dec. 31, 2025 1,255     $ 0   $ 0   $ 0         155,123     2,552   (156,420)  
Shares issued for:                                      
Vesting of restricted share units (in shares)               105                      
Reverse stock split fractional adjustment (in shares)               292                      
Conversion of related-party debt to common stock / Warrants exercised (in shares)               100,000                      
Conversion of related-party debt to common stock 556                       556            
ATM Program / February 2025 private placement (in shares)                 338,616                    
ATM Program / February 2025 private placement   $ 3,682                       $ 3,682          
Stock compensation 36                       36            
Foreign currency translation (301)                             (301)      
Fixed dividends Preferred Series B (635)                       (635)            
Net income (loss) (6,016)                                 (6,016)  
Ending balance (in shares) at Jun. 30, 2026       167,972   1,586,620   667,348                      
Ending balance at Jun. 30, 2026 (1,423)     $ 0   $ 0   $ 0         158,762     2,251   (162,436)  
Beginning balance (in shares) at Mar. 31, 2026       167,972   1,586,620   566,951                      
Beginning balance at Mar. 31, 2026 (2,011)     $ 0   $ 0   $ 0         158,520     2,414   (162,945)  
Shares issued for:                                      
Vesting of restricted share units (in shares)               105                      
Reverse stock split fractional adjustment (in shares)               292                      
Conversion of related-party debt to common stock / Warrants exercised (in shares)               100,000                      
Conversion of related-party debt to common stock 556                       556            
Stock compensation 4                       4            
Foreign currency translation (163)                             (163)      
Fixed dividends Preferred Series B (318)                       (318)            
Net income (loss) 509                                 509  
Ending balance (in shares) at Jun. 30, 2026       167,972   1,586,620   667,348                      
Ending balance at Jun. 30, 2026 $ (1,423)     $ 0   $ 0   $ 0         $ 158,762     $ 2,251   $ (162,436)